StemCells, Inc. Encourages Stockholders to Return Proxies Approving the Microbot Merger by November 14, 2016
27. Oktober 2016 16:31 ET
|
StemCells, Inc.
NEWARK, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) reported today that four of the five proposals presented at the stockholder meeting in connection with the Company’s...
StemCells, Inc. and Microbot Medical Ltd. Announce Strategic Merger
16. August 2016 09:14 ET
|
StemCells, Inc.
NEWARK, Calif. and YOKNEAM, Israel, Aug. 16, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) and Microbot Medical Ltd., a private company organized under the laws of the State of Israel...
StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data
31. Mai 2016 08:15 ET
|
StemCells, Inc.
NEWARK, Calif., May 31, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM) (the “Company”) today announced its decision to terminate the Company’s Phase II Pathway Study in spinal cord injury...
StemCells, Inc. to Report 12-Month Cohort I Data from its Phase II Pathway Study
10. Mai 2016 10:00 ET
|
StemCells, Inc.
NEWARK, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous...
StemCells, Inc. Announces 1-for-12 Reverse Stock Split
06. Mai 2016 12:49 ET
|
StemCells, Inc.
NEWARK, Calif., May 06, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), announced today that at its annual stockholders meeting held on May 5, 2016, the Company's stockholders voted to...
StemCells, Inc. to Participate in the 3rd Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas, NV
27. April 2016 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that management will make a presentation on the Company's programs, pipeline and operations at the...
StemCells, Inc. Presents Interim Results from its Phase II Pathway Study in Chronic Cervical Spinal Cord Injury at ASIA Annual Meeting
18. April 2016 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., April 18, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous...
StemCells, Inc., Pathway™ Study in Cervical Spinal Cord Injury Featured in The Downey Patriot
30. März 2016 16:13 ET
|
StemCells, Inc.
NEWARK, Calif., March 30, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous...
StemCells, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Business Update
23. März 2016 16:05 ET
|
StemCells, Inc.
NEWARK, Calif., March 23, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (NASDAQ:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous...
StemCells, Inc. Announces Updated Timing for Webcast to Discuss Fourth Quarter 2015 Financial Results
21. März 2016 08:05 ET
|
StemCells, Inc.
NEWARK, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing novel cell-based therapeutics for the treatment of serious central nervous...